
Home - Invenra
OUR SERVICES SERVICES Invenra offers flexible options including rapid bispecific discovery and antibody expression. Learn About Our Service Offerings
Invenra - LinkedIn
For those seeking a strategic, partnered approach, Invenra provides tailored support across all stages of discovery, from custom antigen design and assay development to in-depth biological...
Invenra - 2025 Company Profile & Team - Tracxn
Oct 19, 2025 · Explore Invenra's in-depth company profile, including funding details, key investors, leadership, and competitors.
Invenra 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Invenra. Use the PitchBook Platform to explore the full profile.
Invenra Inc - Company Profile and News - Bloomberg Markets
Oct 31, 2011 · Company profile page for Invenra Inc including stock price, company news, executives, board members, and contact information
Invenra - Crunchbase Company Profile & Funding
Invenra touts a broad scientific foundation and a team of scientists with deep expertise in key areas ranging from genomics to biochemistry to bioengineering. Their background is well balanced …
Invenra - Products, Competitors, Financials, Employees, Headquarters ...
Invenra addresses various antibody discovery needs, offering services that include custom antigen design and collaborative development partnerships. It was founded in 2011 and is based in Madison, …
Invenra – Smart Engineering for a Sustain
Aug 2, 2021 · At Invenra, we are a next-generation EPC company at the forefront of innovation in the Marine, Offshore and Onshore Industrial Sectors.
Invenra Company Profile - Office Locations, Competitors ... - Craft
See insights on Invenra including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Invenra - Overview, News & Similar companies | ZoomInfo.com
Jan 5, 2022 · MADISON, Wis.-- (BUSINESS WIRE)--Invenra, Inc., a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology, today announced …